Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,186,600
in 2 filings

Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PERRY MICHAEL S −$1.0M Director sold 9% of stake
  2. OLUKOTUN ADEOYE Y −$174K Director sold 6% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-12-30 Anzalone Christopher Richard Chief Executive Officer Shares withheld for taxes −58,712 $6.13 $360K 561,461
2015-03-06 Lewis David L. Chief Scientific Officer Grant or award · Stock Option +100,000 387,500
2015-03-06 GIVEN BRUCE D Chief Operating Officer Grant or award · Stock Options +60,000 496,000
2015-03-06 Anzalone Christopher Richard President and CEO Grant or award · Stock Options +300,000 1,086,466
2015-03-06 Myszkowski Kenneth Allen CFO Grant or award · Stock Option +50,000 322,000
2015-03-04 GIVEN BRUCE D Chief Operating Officer Grant or award +150,000 275,000
2015-03-04 Anzalone Christopher Richard President and CEO Grant or award +360,000 620,173
2015-03-04 Myszkowski Kenneth Allen CFO Grant or award +50,000 121,500
2015-03-04 McKenney Charles Director Grant or award +25,000 42,220
2015-03-04 FRYKMAN EDWARD W Director Grant or award +25,000 48,852
2015-03-04 PERRY MICHAEL S Director Grant or award +30,000 45,000
2015-03-04 GIVEN DOUGLAS B Director Grant or award +35,000 55,000

Page 38 of 38 · 752 trades